title: Local facial cutaneous vasoconstriction: an unusual complication of inhaled racemic epinephrine in a neonate.
abstract: A term infant treated for post-extubation stridor with nebulized racemic epinephrine developed localized facial blanching due to cutaneous absorption of the aerosolized vasoconstrictor. Local application of heat restored circulation to the afflicted area. This complication of a commonly used medication is not previously reported in the medical literature and has the potential for severe sequelae.
authors.affiliation: 1] Pediatrix Medical Group of California, Ventura, CA, USA [2] Western University of Health Sciences, College of Osteopathic Medicine of the Pacific, Pomona, CA, USA [3] Neonatal Intensive Care Unit, Community Memorial Hospital of San Buenaventura, Ventura, CA, USA.
authors.forename: B O S
authors.initials: BO
authors.lastname: Bengtsson
authors.forename: L A
authors.initials: LA
authors.lastname: Spink
authors.forename: J B
authors.initials: JB
authors.lastname: Grone
mesh_terms: D000280:Administration, Inhalation; D005145:Face / Q000098:blood supply*; D006801:Humans; D007231:Infant, Newborn; D008297:Male; D064705:Racepinephrine / Q000009:adverse effects*; D014661:Vasoconstriction; D014662:Vasoconstrictor Agents / Q000009:adverse effects*
chemical_list: D014662:Vasoconstrictor Agents; D064705:Racepinephrine